AMPA-VEGA Trademark
Trademark Overview
On Monday, December 30, 2024, a trademark application was filed for AMPA-VEGA with the United States Patent and Trademark Office. The USPTO has given the AMPA-VEGA trademark a serial number of 98927799. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, March 31, 2026. This trademark is owned by Neurocrine Biosciences, Inc.. The AMPA-VEGA trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical research and development services; scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical preparations; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; pharmaceutical research and development services in the field of anhedonia, major depressive disorder and mood disorders; scientific research in the nature of conducting clinical trials for others for pharmaceutical preparations for the treatment and prevention of anhedonia, major depressive disorder and mood disorders; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations for the treatment and prevention of anhedonia, major depressive disorder and mood disorders, and evaluating epidemiological results ...
Providing medical information; providing medical information relating to therapies and treatments for anhedonia, major depressive disorder and mood disorders
General Information
| Serial Number | 98927799 |
| Word Mark | AMPA-VEGA |
| Filing Date | Monday, December 30, 2024 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, March 31, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 3, 2026 |
Trademark Statements
| Goods and Services | Pharmaceutical research and development services; scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical preparations; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; pharmaceutical research and development services in the field of anhedonia, major depressive disorder and mood disorders; scientific research in the nature of conducting clinical trials for others for pharmaceutical preparations for the treatment and prevention of anhedonia, major depressive disorder and mood disorders; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations for the treatment and prevention of anhedonia, major depressive disorder and mood disorders, and evaluating epidemiological results for treatments for anhedonia, major depressive disorder and mood disorders; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials pertaining to therapies and treatments for anhedonia, major depressive disorder and mood disorders |
| Goods and Services | Providing medical information; providing medical information relating to therapies and treatments for anhedonia, major depressive disorder and mood disorders |
| Pseudo Mark | AMPA VEGA |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 30, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 30, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Neurocrine Biosciences, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92130
US |
| Party Name | Neurocrine Biosciences, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92130
US |
Trademark Events
| Event Date | Event Description |
| Monday, December 30, 2024 | NEW APPLICATION ENTERED |
| Thursday, March 20, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, March 20, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, March 20, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Sunday, June 1, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, June 4, 2025 | ASSIGNED TO EXAMINER |
| Sunday, June 8, 2025 | NON-FINAL ACTION WRITTEN |
| Sunday, June 8, 2025 | NON-FINAL ACTION E-MAILED |
| Sunday, June 8, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, August 22, 2025 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Friday, August 22, 2025 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Monday, December 8, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, December 8, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, December 8, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, January 7, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, January 28, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 3, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, February 3, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 31, 2026 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
